Essential for electric cars, medical scanners and weaponry, the EU is almost totally reliant on China for the materials used in rare earth magnets. The race is on to open new mines, develop alternatives, reduce waste and recycle more
The Czech presidency of the Council of the EU starts on Friday with plans to focus on research infrastructures, synergies and a new strategy for European innovation
Policymakers promised to make the new generation of public-private research partnerships easier to manage. But a year after they started the jury is still out, as a Science|Business conference hears
With the European Parliament due to report on the progress to date of the EIC, universities are keen to see intellectual property rules put up for revision
Democracies launch $600B Partnership for Global Infrastructure to compete with Beijing. But critics say it is a rehash of existing schemes which have made little progress during the past year
IMI project RESCEU is shedding new light on the burden of respiratory syncytial virus, a common infectious disease that can cause serious illness in young children and other vulnerable groups.
In this podcast, Jesper Kjær, director of the Danish Medicines Agency's Data Analytics Center explains how the agency is doubling down on the use of real-world data to support its regulatory decision-making.
In the first podcast related to the Future-Proofing Medicines initiative, Kjær explains how data can be used to support both the reimbursement and repurposing of medicines, bringing benefits to people beyond those for whom the medicines were originally developed. He also explains how the European Health Data Space will help drive a common language, definitions around good quality and build the necessary infrastructure across the EU.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.